Organigram Global (OGI) Non-Current Deferred Tax Liability (2018 - 2023)
Organigram Global (OGI) posted quarterly Non-Current Deferred Tax Liability of $10.3 million for Q3 2023, up 265.57% quarter-over-quarter from $2.8 million in Q3 2022.
Organigram Global (OGI) Non-Current Deferred Tax Liability (2018 - 2023) Analysis & Trends
Organigram Global (OGI) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $10.3 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Non-Current Deferred Tax Liability changed N/A year-over-year to $10.3 million; the TTM figure through Sep 2023 stood at $10.3 million (changed N/A YoY), while the FY2023 annual figure was $10.3 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability advanced to $10.3 million in Q3 2023 per OGI's latest filing, from $2.8 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $16.8 million in Q2 2019 and bottomed at $2.8 million in Q3 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $11.2 million across 4 years, with a median of $10.3 million in 2023.
- On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 14.79% in 2019 and fell as far as 14.79% in 2019.
- Organigram Global's Non-Current Deferred Tax Liability stood at $16.0 million in 2019, then plunged by 37.73% to $10.0 million in 2020, then slumped by 71.84% to $2.8 million in 2022, then soared by 265.57% to $10.3 million in 2023.
- Business Quant data shows OGI's Non-Current Deferred Tax Liability at $10.3 million in Q3 2023, $2.8 million in Q3 2022, and $10.0 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Organigram Global | 150.72 Mn | 150.60 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10.27 Mn |
| Sep 30, 2023 | 10.27 Mn |
| Aug 31, 2022 | 2.81 Mn |
| Aug 31, 2022 | 2.81 Mn |
| Feb 29, 2020 | 9.98 Mn |
| Feb 29, 2020 | 9.98 Mn |
| Aug 31, 2019 | 16.02 Mn |
| Aug 31, 2019 | 16.02 Mn |
| May 31, 2019 | 16.76 Mn |
| May 31, 2019 | 16.76 Mn |
| Aug 31, 2018 | 13.96 Mn |
| Aug 31, 2018 | 13.96 Mn |